We provide excellent quality services in the early phases of drug discovery with the aim of generating new valuable leads. We develop customized cell-free and cell-based in-vitro assays covering a broad range of target classes, run high-throughput screening campaigns to identify hit compounds from both our high-quality compound collections (synthetic and natural) or those provided by our clients, using a variety of detection technologies, and support the hit-to-lead program of our clients to identify the most promising leads.